IGF1R and esophageal squamous cell carcinoma: An IGF1R inhibitor (PQ401) reduced ESCC cell proliferation (Figure S7A and S7B) and synergised with gefitinib in TE-11 cells (Figure S7C), which is consistent with data using different ESCC cell lines and inhibitors [39].